Overview

Velcade in MALT Lymphoma Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Bortezomib for treatment of disseminated MALT lymphoma or at relapse following HP -eradication,or chemotherapy or radiation.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of Vienna
Treatments:
Bortezomib